TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Beery-Buktenica VMI Test 6th Edition (Short Form)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Aerosol concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in pain related disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: CAD4TB cut-off value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Afinion CRP assay cut-off value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gingival Volumetric Variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with peripheral blood antibodies against SARS-COV2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Pressure pain threshold (PPT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: mirobiome difference of the fecal between IBS and health controls
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Metabolic changes between IBS and Healthy controls
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Blood Pressure (BP) during tilt testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Brief Symptom Inventory scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Willingness to have a teleconsultation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: RBC membrane fatty acid profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total Corneal Staining Score (TCSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of TGS for globin gene mutation detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of causality of adverse drug reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Specific antibody (IgG) response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Ad libitum energy intake (kcal)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time until application for nursing home admission
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Severe intubation-related complications
Endpoint domain: Adverse events/effects
Primary endpoint: Urinary aspects
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Sexual aspects
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pelvic and Perineal aspect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ano-rectal aspect
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Tube free survival
Endpoint domain: Mortality/survival
Primary endpoint: percentage of gastrointestinal bleeding disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Days of life free of stay in the Intensive Care Unit
Endpoint domain: Mortality/survival
Primary endpoint: Quality of samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in IL-1, IL-6, CXCL10 and Immune Cell Population
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in the MADRS10 total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in CGM Time in Range (TIR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Pain 1 hour after ERCP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Genetic testing attitudes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: medication effectiveness in peripheral vertigo
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of non-CNS EMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Existence of risk factors and mental disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients diagnosed with iron deficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Gains in WM training task performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in brain activation within the WM network
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of Participants Experiencing Dose-limiting Toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Recommended Phase 2 Dose (RP2D) of MEN2312
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Complete gross surgical resection (R0 or R1 resection)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Accuracy of CSE-MRI method
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean absolute error between predicted and actual EMA scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent of subjects demonstrating improvement in EMANet prediction over time
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in inotropic score after 72h
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Ulcer Lesion Assessment PG Target Lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in facial wrinkles and lines
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Facial Appearance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Assessment of Wrinkle Severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of psychiatric disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and feasibility of T-cells
Endpoint domain: Adverse events/effects
Primary endpoint: Number of recurrent ankle sprains
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of episodes of the ankle giving way
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of chronic ankle instability related symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived Menstrual Cycle Symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 2-Minute Walk Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle tone (Hz)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stiffness (N/m)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Ranking Score (mRS) at 90 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cancer Treatment Impact
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Pictorial Blood Assessment Chart (PBAC) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Sexual Function Questionnaire-14 total score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Levels of different markers in MS diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: treatment-related dose-limiting toxicity (DLT) rate
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency and Severity Of Treatment-Emergent Adverse Events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Dose-Limiting Toxicities (DLTS)
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in fluid overload
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain recurrence
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of disabled migraine days
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Percentage of enrolled participants who complete the MIST intervention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Patient satisfaction or MIST app: Client Satisfaction Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reading comprehension improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change on the Western Aphasia Battery (WAB) - Aphasia Quotient
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change from baseline in absolute FVC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Cmax of ASN51
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tmax of ASN51
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-tau of ASN51
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent body weight lost at 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in physical literacy
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Incidence of postoperative JET
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients with neutralizing antibody titer > 1/10
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: final distance walked by the 6-minute walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time difference of Timed up and go' test (TUG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time difference of 10-step stair test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of Illness - Apache II
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Little Irregularity Index (LII)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in scores of Modified Ashworth scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in scores of GMFM 88
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Functionality
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Stigmatization
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from Baseline in All-Cause Mortality
Endpoint domain: Mortality/survival
Primary endpoint: Change in motor functioning and sensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change dexterity of the upper limb
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent Change in A Continuous Glucose Monitor (CGM) Coefficient of Variation (CV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percent Change of C-reactive Protein (CRP) Biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent Change in Concentration of Interleukin-6 (IL-6) Biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percent Change in Concentration of Tumor Necrosis Factor-alpha (TNFα) Biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in risk of substance exposed pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: The International Consultation on Incontinence Questionnaire-ICIQ
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Fecal Incontinence Severity Index-FISI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Distinguish between patients with and without pulmonary hypertension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Distinguish between patients with pre-capillary hypertension and post-capillary hypertension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Adherence to prescribed exercise program
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oswestry Disability Index Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Clinical complete response (CR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pulp/tooth volume ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: endothelial function by flow mediated dilation (FMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: endothelial function by strain gauge plethysmography as change in forearm blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: arterial stiffness with peak wave velocity (PWV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in OABSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Additional Adenoma Detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Performance of GALAD for liver cancer early detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Maximum Tolerated Dose (MTD) or Maximum Administered Dose (MAD) of BGB-B2033
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Recommended Phase 2 dose (RP2D) of BGB-B2033 alone and in combination with tislelizumab
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: DLCO (Diffusing Capacity of the Lung for Carbon Monoxide)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Difference in lesion size after treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cohen's k coefficient of Gram Stain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to get up and go (TGUG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: short physical performance battery (SPPB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postoperative deep venous thrombosis
Endpoint domain: Adverse events/effects
Primary endpoint: saphenous nerve injury
Endpoint domain: Adverse events/effects
Primary endpoint: subcutaneous induration
Endpoint domain: Adverse events/effects
Primary endpoint: Rhythm discrimination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of R0 resections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Functional connectivity of brain networks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Days Alive and At Home
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change from Baseline in Basic Psychological Need Satisfaction at Post Intervention
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from Baseline in Basic Psychological Need Frustration at Post Intervention
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from Baseline in Ability to Participate in Social Roles and Activities at Post Intervention
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Changes of Total Energy Expenditure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes of Resting Energy Expenditure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes of Physical Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: parasite clearance time (PCT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: polymerase chain reaction (PCR) corrected adequate clinical and parasitological response (ACPR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NAD metabolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Patient's Perception of Nursing Care Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Frequency of resolution of hepatic steatosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Activation and use of the technology
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: eligibility rates
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: participation rates
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: qualitative assessment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: renal dysfunction at least grade 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Number of Participants Classified According to Treatment Pattern
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Time to first occurrence of cardiovascular (CV) death or HF event
Endpoint domain: Mortality/survival
Primary endpoint: Time spent on drug administration activities
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Pulmonary Hypertension Functional Class
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Patient Perception of Parenteral Infusion System
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Autoregulation index (ARI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cerebral Oxymetry index (CoX)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: number of patients developing cerebrovascular adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Prevalence of impaired fibrinolysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Reduction in Erythema
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Attention and speed of information processing
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Social cognition
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Number of participants who enroll in smoking cessation treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Invasive breast cancer incidence at 3 years
Endpoint domain: Mortality/survival
Primary endpoint: Invasive breast cancer incidence at 6 years
Endpoint domain: Mortality/survival
Primary endpoint: Clinical Sensitivity in classifying early gastric cancer based on the depth of invasion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Clinical Specificity in classifying early gastric cancer based on the depth of invasion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Heart Failure Disease Status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Neuropathic Pain Quality
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Participants with 50% Stenosis Identified
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Induction of labour-delivery interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient satisfaction with the quality of nursing care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Ocular treatment emergent adverse events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Time to Confirmed Worsening in MDS-UPDRS Parts II and III Combined Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge transfer effectiveness
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Proportion of participants with confirmed culprit cephalosporin allergy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: modified Radiation Induced Skin Reaction Assessment Scale (mRISRAS) scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Pelvic Angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frontal Pelvic Angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mullen Scale of Early Learning (MSEL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peabody Developmental Motor Scales, Second Edition (PDMS2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child Behavior Checklist for Ages 1.5-5 (CBCL/1.5-5)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Area Under the Serum Concentration-time Curve from Day 1 to Week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Serum Concentration-time Curve from Day 1 to Day 15
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes